BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pijl ME, Doornbos J, Wasser MN, van Houwelingen HC, Tollenaar RA, Bloem JL. Quantitative analysis of focal masses at MR imaging: a plea for standardization. Radiology. 2004;231:737-744. [PMID: 15163813 DOI: 10.1148/radiol.2313030173] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Swensen SJ, Johnson CD. Radiologic Quality and Safety: Mapping Value Into Radiology. Journal of the American College of Radiology 2005;2:992-1000. [DOI: 10.1016/j.jacr.2005.08.003] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 3.3] [Reference Citation Analysis]
2 O’regan DP, Callaghan MF, Fitzpatrick J, Naoumova RP, Hajnal JV, Schmitz SA. Cardiac T2* and lipid measurement at 3.0 T-initial experience. Eur Radiol 2008;18:800-5. [DOI: 10.1007/s00330-007-0814-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
3 Roberts DW, Valdés PA, Harris BT, Fontaine KM, Hartov A, Fan X, Ji S, Lollis SS, Pogue BW, Leblond F. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article. J Neurosurg. 2011;114:595-603. [PMID: 20380535 DOI: 10.3171/2010.2.jns091322] [Cited by in Crossref: 183] [Cited by in F6Publishing: 97] [Article Influence: 15.3] [Reference Citation Analysis]
4 Olsen ØE, Sebire NJ. Apparent diffusion coefficient maps of pediatric mass lesions with free-breathing diffusion-weighted magnetic resonance: feasibility study. Acta Radiol 2006;47:198-204. [DOI: 10.1080/02841850500479651] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
5 Krestin GP. Commoditization in radiology: threat or opportunity? Radiology 2010;256:338-42. [PMID: 20656828 DOI: 10.1148/radiol.10100144] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
6 O'regan DP, Fitzgerald J, Allsop J, Gibson D, Larkman DJ, Cokkinos D, V Hajnal J, Schmitz SA. A comparison of MR cholangiopancreatography at 1.5 and 3.0 Tesla. BJR 2005;78:894-8. [DOI: 10.1259/bjr/28094700] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
7 Merkle EM, Nour SG, Lewin JS. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months. Radiology 2005;235:1065-71. [PMID: 15914485 DOI: 10.1148/radiol.2353040871] [Cited by in Crossref: 90] [Cited by in F6Publishing: 69] [Article Influence: 5.3] [Reference Citation Analysis]
8 Al-Dahery S, McGee A, Rainford L, Khashoggi K, Misha N. Evaluation of unenhanced axial T1W and T2W liver MR images acquired from institutions within the Republic of Ireland and the Kingdom of Saudi Arabia. Radiography (Lond) 2019;25:e45-51. [PMID: 30955698 DOI: 10.1016/j.radi.2018.10.005] [Reference Citation Analysis]
9 Wu T, Zheng WL, Zhang SZ, Sun JH, Yuan H. Bimodal visualization of colorectal uptake of nanoparticles in dimethylhydrazine-treated mice. World J Gastroenterol 2011; 17(31): 3614-3622 [PMID: 21987608 DOI: 10.3748/wjg.v17.i31.3614] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
10 Schindera ST, Merkle EM, Dale BM, Delong DM, Nelson RC. Abdominal magnetic resonance imaging at 3.0 T what is the ultimate gain in signal-to-noise ratio? Acad Radiol. 2006;13:1236-1243. [PMID: 16979073 DOI: 10.1016/j.acra.2006.06.018] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
11 Stobo DB, Lindsay RS, Connell JM, Dunn L, Forbes KP. Initial experience of 3 Tesla versus conventional field strength magnetic resonance imaging of small functioning pituitary tumours. Clin Endocrinol (Oxf) 2011;75:673-7. [PMID: 21609346 DOI: 10.1111/j.1365-2265.2011.04098.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
12 Brown AD, Marotta TR. Using machine learning for sequence-level automated MRI protocol selection in neuroradiology. J Am Med Inform Assoc 2018;25:568-71. [PMID: 29092082 DOI: 10.1093/jamia/ocx125] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
13 Siegel AB, Cohen EI, Ocean A, Lehrer D, Goldenberg A, Knox JJ, Chen H, Clark-Garvey S, Weinberg A, Mandeli J, Christos P, Mazumdar M, Popa E, Brown RS Jr, Rafii S, Schwartz JD. Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma. J Clin Oncol. 2008;26:2992-2998. [PMID: 18565886 DOI: 10.1200/jco.2007.15.9947] [Cited by in Crossref: 317] [Cited by in F6Publishing: 154] [Article Influence: 22.6] [Reference Citation Analysis]
14 Miao TL, Kielar AZ, Hibbert RM, Schieda N. Utility of T1-weighted MRI as a predictor of liver lesion visibility on ultrasound: A clinical tool to determine feasibility of ultrasound-guided percutaneous interventions. Eur J Radiol 2017;90:256-61. [PMID: 28583643 DOI: 10.1016/j.ejrad.2017.03.004] [Reference Citation Analysis]
15 Siegel AB, Cohen EI, Ocean A, Lehrer D, Goldenberg A, Knox JJ, Chen H, Clark-Garvey S, Weinberg A, Mandeli J. Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma. J Clin Oncol. 2008;26:2992-2998. [PMID: 18565886 DOI: 10.1200/jco.2007.15.9947.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Ananthakrishnan G, Macnaught G, Hinksman L, Gilmour H, Forbes KP, Moss JG. Diffusion-weighted imaging in uterine artery embolisation: do findings correlate with contrast enhancement and volume reduction? Br J Radiol 2012;85:e1046-50. [PMID: 22898156 DOI: 10.1259/bjr/91540172] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]